Stenta Marco, Dal Peraro Matteo
Laboratory for Biomolecular Modeling, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology-EPF Lausanne, Switzerland.
Front Biosci (Elite Ed). 2011 Jun 1;3(3):1061-78. doi: 10.2741/e311.
The advent of molecular medicine allowed identifying the malfunctioning of subcellular processes as the source of many diseases. Since then, drugs are not only discovered, but actually designed to fulfill a precise task. Modern computational techniques, based on molecular modeling, play a relevant role both in target identification and drug lead development. By flanking and integrating standard experimental techniques, modeling has proven itself as a powerful tool across the drug design process. The success of computational methods depends on a balance between cost (computation time) and accuracy. Thus, the integration of innovative theories and more powerful hardware architectures allows molecular modeling to be used as a reliable tool for rationalizing the results of experiments and accelerating the development of new drug design strategies. We present an overview of the most common quantum chemistry computational approaches, providing for each one a general theoretical introduction to highlight limitations and strong points. We then discuss recent developments in software and hardware resources, which have allowed state-of-the-art of computational quantum chemistry to be applied to drug development.
分子医学的出现使人们能够将亚细胞过程的功能失调确定为许多疾病的根源。从那时起,药物不仅是被发现,而且实际上是被设计来完成一项精确任务的。基于分子建模的现代计算技术在靶点识别和药物先导物开发中都发挥着重要作用。通过辅助和整合标准实验技术,建模已证明自身是贯穿药物设计过程的强大工具。计算方法的成功取决于成本(计算时间)和准确性之间的平衡。因此,创新理论与更强大硬件架构的整合使分子建模能够用作一种可靠工具,用于使实验结果合理化并加速新药物设计策略的开发。我们概述了最常见的量子化学计算方法,为每种方法提供一般性理论介绍,以突出其局限性和优点。然后我们讨论软件和硬件资源的最新进展,这些进展使计算量子化学的最新技术能够应用于药物开发。